Outpost Bio Ltd

Deep Biotech

Funding stage: Pre-seed
Technology type: Platform Technology
Western Central London

Email: [email protected]
Website: https://www.outpost.bio
Membership category: Emerging Y1

27, Courtney Road, London, N7 7BQ, United Kingdom

Outpost Bio Ltd at a glance

Decoding the hidden interactions that drive human biology.

About Outpost Bio Ltd

Outpost Bio combines high-throughput assays of human-derived microbial communities with machine learning to build frontier models that reveal causal pathways. Headquartered in Boston and London, the company enables any partner developing molecules that go into or onto humans to predict microbiome-mediated metabolism, toxicity, and response. Founded by Jenny Yang (Oxford PhD, clinical AI) and Alex Merwin (former Amazon/AWS Health & Bio).

Therapeutic area(s)

Small molecules
All therapeutic areas

Articles Outpost Bio Ltd has contributed to

4 March 2026

Outpost Bio raises $3.5 million pre-seed to build frontier models for human microbiology

Outpost Bio has raised $3.5 million in pre-seed funding to build frontier AI models that make human microbiology computable, enabling more precise prediction and optimization of intervention outcomes.

Member news